Medifast (FRA:MDF) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 07, 2026)


FRA:MDF Medifast Inc FRA:MDF
68 GF Score
Price €9.13
GF Value €6.97
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Medifast 5-Year Yield-on-Cost %?

Medifast FRA:MDF +0.55% 68 5-Year Yield-on-Cost % is 0.00 as of Jul. 07, 2026. GuruFocus rates FRA:MDF with a GF Score™ of 68/100 and a GF Value™ of €6.97 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 48 Personal Services companies, Medifast ranks worse than 2083331.25% on this metric.

Medifast's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for Medifast's 5-Year Yield-on-Cost % or its related term are showing as below:


During the past 13 years, Medifast's highest Yield on Cost was 16.74. The lowest was 0.71. And the median was 2.65.


FRA:MDF's 5-Year Yield-on-Cost % is not ranked *
in the Personal Services industry.
Industry Median: 3.405
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Medifast  (FRA:MDF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Medifast 5-Year Yield-on-Cost % Related Terms


FRA:MDF vs RGS, EVTK, DROR: 5-Year Yield-on-Cost % Comparison

For the Personal Services subindustry, Medifast's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medifast 5-Year Yield-on-Cost % vs Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, Medifast's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Medifast's 5-Year Yield-on-Cost % falls into.


FRA:MDF
68GF Score
Medifast Inc FRA:MDF
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medifast 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Medifast is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Medifast (FRA:MDF) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 07, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medifast and its competitors. Over the past decade, Medifast's 5-Year Yield-on-Cost % has ranged from 0.71 to 16.74. According to the industry distribution chart, Medifast ranks #999999 out of 48 companies in the Personal Services industry.
Is Medifast's 5-Year Yield-on-Cost % too high?
Medifast's current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 0.71 to a high of 16.74. Based on the distribution chart, Medifast ranks #999999 out of 48 companies in the Personal Services industry, which is in the bottom quartile relative to peers. Overall, Medifast has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medifast's 5-Year Yield-on-Cost % compare to RGS and EVTK?
According to the Personal Services industry distribution chart, Medifast ranks #999999 out of 48 companies for 5-Year Yield-on-Cost %. This places Medifast in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.41. Historically, Medifast's own 5-Year Yield-on-Cost % has ranged from 0.71 to 16.74 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Personal Services company?
The median 5-Year Yield-on-Cost % among Personal Services companies is 3.41, based on 48 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medifast and its competitors. For the Personal Services industry, the median 5-Year Yield-on-Cost % is 3.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medifast's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medifast stock overvalued right now?
Based on GuruFocus' analysis, Medifast (FRA:MDF) is currently considered Significantly Overvalued. The stock's GF Value™ is €6.97, compared to a current price of €9.13 — trading 31% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Medifast's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Medifast (FRA:MDF), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medifast (FRA:MDF) Overvalued in 2026?

Based on GuruFocus' analysis, Medifast stock appears to be overvalued. The current stock price of €9.13 is trading 31% above its estimated GF Value™ of €6.97. GuruFocus considers Medifast to be Significantly Overvalued.

Key valuation signals for FRA:MDF:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: €6.97 vs. price of €9.13 (31% above fair value)
  • GF Score™: 68/100 with 2 warning signs

No single metric tells the full story. See the FRA:MDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medifast Business Description

Other Exchanges MED:USA0K05:UKMDF:Germany
Address 100 International Drive, Baltimore, MD, USA, 21202
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
68GF Score

Get the complete analysis for FRA:MDF

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.13
Price
€6.97
GF Value